dr. J. (Jan) Westerink

dr. J. (Jan) Westerink

Assistant Professor - medical

Show full profile

Research Output (138)

Post-thrombotic syndrome after upper extremity deep vein thrombosis:An international Delphi consensus study

de Kleijn Robert J C M F, Schropp Ludo, van Hattum Eline S, Ünlu Çagdas, Middeldorp Saskia, Nijkeuter Mathilde, Westerink Jan, Petri Bart-Jeroen, de Borst Gert J 20 Aug 2022, In: Journal of thrombosis and haemostasis : JTH. 20 , p. 1880-1886 7 p.

Lifestyle changes and kidney function:A 10-year follow-up study in patients with manifest cardiovascular disease

Østergaard Helena Bleken, Demirhan Imre, Westerink Jan, Verhaar Marianne C, Asselbergs Folkert W, de Borst Gert J, Kappelle L Jaap, Visseren Frank L J, van der Leeuw Joep, 17 May 2022, In: European Journal of Clinical Investigation. 52

Modifiable risk factors in adults with and without prior cardiovascular disease:findings from the Indonesian National Basic Health Research

Arsyad Dian Sidik, Westerink Jan, Cramer Maarten J., Ansar Jumriani, Wahiduddin , Visseren Frank L.J., Doevendans Pieter A., Ansariadi 5 Apr 2022, In: BMC Public Health. 22 , p. 1-11

Prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with surrogate markers of insulin resistance in patients with type 1 diabetes

de Vries Marieke, Westerink Jan, El-Morabit Fatima, Kaasjager H. A.H.(Karin), de Valk Harold W. Apr 2022, In: Diabetes Research and Clinical Practice. 186 , p. 1-7

Chronic kidney disease and atrial fibrillation:A dangerous combination

Ocak Gurbey, Khairoun Meriem, Khairoun Othman, Bos Willem Jan W, Fu Edouard L, Cramer Maarten J, Westerink Jan, Verhaar Marianne C, Visseren Frank L, Apr 2022, In: PLoS ONE. 17 , p. 1-13

Screen-detected abnormal ankle brachial index:A risk indicator for future cardiovascular morbidity and mortality in patients with manifest cardiovascular disease

Jagt Vivianne L., Hazenberg Constantijn E.V.B., Kapelle Jaap, Cramer Maarten J., Visseren Frank L.J., Westerink Jan 10 Mar 2022, In: PLoS ONE. 17 , p. 1-17

Protocollaire diabeteszorg:Een praktische uitwerking van de NHG-standaard Diabetes mellitus type 2, editie 2022-2023

Houweling Bas, Bakker Suzanne, Hart B, Dogger-van Nieuwenhoven Petra, Willink Martin, Bilo Henk, Westerink Jan 3 Mar 2022, 191 p.

Impact of a Patient’s Baseline Risk on the Relative Benefit and Harm of a Preventive Treatment Strategy:Applying Trial Results in Clinical Decision Making

de Vries Tamar I., Stam-Slob Manon C., Peters Ron J.G., van der Graaf Yolanda, Westerink Jan, Visseren Frank L.J. 4 Jan 2022, In: Journal of the American Heart Association. 11 , p. 1-17

Patients with diffuse idiopathic skeletal hyperostosis have an increased burden of thoracic aortic calcifications

Harlianto Netanja I., Westerink Jan, Hol Marjolein E., Wittenberg Rianne, Foppen Wouter, Van Der Veen Pieternella H., Van Ginneken Bram, Verlaan Jorrit Jan, De Jong P. A., Mohamed Hoesein Firdaus A.A., Asselbergs F. W., Nathoe H. M., De Borst G. J., Bots M. L., Geerlings M. I., Emmelot M. H., De Jong P. A., Leiner T., Lely A. T., Van Der Kaaij N. P., Kappelle L. J., Ruigrok Y. M., Verhaar M. C., Visseren F. L.J. 2022, In: Rheumatology advances in practice. 6 , p. rkac060

Non-alcoholic fatty liver disease:identical etiologic factors in patients with type 1 and type 2 diabetes

de Vries Marieke, El-Morabit Fatima, van Erpecum Karel J., Westerink Jan, Bac Simon T., Kaasjager H. A.H.(Karin), de Valk Harold W. 2022, In: European journal of internal medicine. 100 , p. 77-82 6 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht





Practical uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not